Search Results

An analysis of the 2022 DAWN data presents: (1) nationally representative weighted estimates of all drug-related emergency department (ED) visits, (2) nationally representative weighted estimates of the top substances involved in drug-related ED visits, including rates by race and ethnicity; (3) nationally representative weighted estimates of opioid-related ED visits...

An analysis of final 2021 DAWN data presents: (1) nationally representative weighted estimates, including percent and unadjusted rates per 100,000, for all drug-related ED visits, (2) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (3) the assessment of monthly trends and drugs involved in polysubstance...

Preliminary Findings from Drug-Related Emergency Department Visits, 2021. An analysis of 2021 preliminary data presents (1) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (2) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (3)...

This report uses 2012 Medical Expenditure Panel Survey (MEPS) data. Adults aged 18 to 64 in poor physical health who also reported behavioral health conditions (i.e., mental health or substance use disorders) had higher total health care expenditures than adults in poor health without behavioral health conditions. These higher total...

This CBHSQ short report uses MEPS data to analyze behavioral health expenditures for adults aged 18 to 64 were eligible for both Medicaid and Medicare (dual eligible) during any given year from 2008 to 2011.

Abstract The National Survey on Drug Use and Health (NSDUH) and the Arrestee Drug Abuse Monitoring (ADAM) Program provide information on alcohol and drug use by individuals who have recently been arrested. The studies differ in their target populations (civilian, noninstitutionalized individuals vs. arrestees in 39 sites recently booked into...

This study used data from the public use files of the 1997 to 2004 National Health Interview Survey (NHIS), which were linked to death certificate data from the 1997 to 2006 National Death Index (NDI), to assess the association between psychological distress and mortality.

This study used data from the public use files of the 1997 to 2004 National Health Interview Survey (NHIS), which were linked to death certificate data from the 1997 to 2006 National Death Index (NDI), to assess the association between psychological distress and mortality. This study summarizes results presented in...

This Drug Abuse Warning Network (DAWN) short report looks at the estimated number of emergency room visits for adverse reactions involving involving the prescription sleep qie zolpidem for 2005 through 2010. The report focuses on gender, age groups and other pharmaceuticals such as pain relievers, other anti-anxiety and insomnia medications...

This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency room visits involving attention deficit/hyperactivity disorder stimulant medications between 2005 and 2010. The report shows visits for nonmedical use, adverse reactions, visits involving other pharmaceuticals, illicit drugs or alcohol.

This Drug Abuse Warning Network (DAWN) report shows emergency room visits in 2010 involving synthetic cannabinoid products commonly called \"Spice\" or \"K2\". These drugs are also known as synthetic marijuana,

This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits made by homeless and the follow-up care from 2009 to 2010.

This publication provides behavioral health statistics at the national and state levels from multiple data sources, including the National Survey on Drug Use and Health, the National Health Interview Survey, the Medical Expenditures Panel Survey, the National Association of State Mental Health Program Directors, as well as peer-reviewed journal articles.

This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency department visits involving phencyclidine (PCP) between 2005 and 2011. The report specifically talks about age groups, gender and other drugs such as marijuana, cocaine, heroin and pharmaceuticals and trends over time.